Yellow fever virus strains Asibi and 17D-204 infect human umbilical cord endothelial cells and induce novel changes in gene expression

Virology

Volumn 342, Issue 2, 2005, Pages 167-176

  Khaiboullina, Svetlana F ^a   Rizvanov, Albert A ^a   Holbrook, Michael R ^b,c   St Jeor, Stephen ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Chemokine; Cytokine; Endothelial cells; Yellow fever

Indexed keywords

CHEMOKINE; CYTOKINE; FIBRIN; FIBRINOGEN; INTERFERON INDUCING AGENT; INTERLEUKIN 6; PROTEIN BCL 2; PROTEIN CIG5; PROTEIN P78; RANTES; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; MOLECULAR WEIGHT; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD; VASCULAR ENDOTHELIUM; VIRUS HEMORRHAGIC FEVER; VIRUS INFECTION; VIRUS STRAIN; VIRUS VIRULENCE; YELLOW FEVER FLAVIVIRUS;

ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HUMANS; INTERLEUKIN-6; RANTES; UMBILICAL CORD; VIRUS REPLICATION; YELLOW FEVER VIRUS;

ANIMALIA; YELLOW FEVER VIRUS;

EID: 27644585314     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.07.035     Document Type: Article

References (41)

1. M. Aebi, J. Fah, N. Hurt, C.E. Samuel, D. Thomis, L. Bazzigher, J. Pavlovic, O. Haller, and P. Staeheli cDNA structures and regulation of two interferon-induced human Mx proteins Mol. Cell. Biol. 9 1989 5062 5072
2. P. Avirutnan, P. Malasit, B. Seliger, S. Bhakdi, and M. Husmann Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis J. Immunol. 161 1998 6338 6346
3. D.S. Burke, and T.P. Monath Flaviviruses D.M. Knipe P.M. Howley Virology 2001 Lippincott Williams and Wilkins Philadelphia 1043 1125
4. N. Cammack, and E.A. Gould Topographical analysis of epitope relationships on the envelope glycoprotein of yellow fever 17D vaccine and the wild type Asibi parent virus Virology 150 1986 333 341
5. P.A. Cane, and E.A. Gould Immunoblotting reveals differences in the accumulation of envelope protein by wild-type and vaccine strains of yellow fever virus J. Gen. Virol. 70 Pt. 3 1989 557 564
6. A. Catteau, O. Kalinina, M.C. Wagner, V. Deubel, M.P. Courageot, and P. Despres Dengue virus M protein contains a proapoptotic sequence referred to as ApoptoM J. Gen. Virol. 84 2003 2781 2793
7. A. Catteau, G. Roue, V.J. Yuste, S.A. Susin, and P. Despres Expression of dengue ApoptoM sequence results in disruption of mitochondrial potential and caspase activation Biochimie 85 2003 789 793
8. K.C. Chin, and P. Cresswell Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus Proc. Natl. Acad. Sci. U.S.A. 98 2001 15125 15130
9. M.O. Diaz, S. Ziemin, M.M. Le Beau, P. Pitha, S.D. Smith, R.R. Chilcote, and J.D. Rowley Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines Proc. Natl. Acad. Sci. U.S.A. 85 1988 5259 5263
10. J.W. Fenton, F.A. Ofosu, D.V. Brezniak, and H.I. Hassouna Understanding thrombin and hemostasis Hematol. Oncol. Clin. North Am. 7 1993 1107 1119
11. M. Frese, G. Kochs, H. Feldmann, C. Hertkorn, and O. Haller Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein J. Virol. 70 1996 915 923
12. E. Gordien, O. Rosmorduc, C. Peltekian, F. Garreau, C. Brechot, and D. Kremsdorf Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein J. Virol. 75 2001 2684 2691
13. U.T. Hacker, T. Jelinek, S. Erhardt, A. Eigler, G. Hartmann, H.D. Nothdurft, and S. Endres In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination J. Infect. Dis. 177 1998 774 778
14. C.S. Hahn, J.M. Dalrymple, J.H. Strauss, and C.M. Rice Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it Proc. Natl. Acad. Sci. U.S.A. 84 1987 2019 2023
15. O. Haller, and G. Kochs Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity Traffic 3 2002 710 717
16. O. Haller, M. Frese, and G. Kochs Mx proteins: mediators of innate resistance to RNA viruses Rev. Sci. Tech. 17 1998 220 230
17. M. Kanerva, K. Melen, A. Vaheri, and I. Julkunen Inhibition of puumala and tula hantaviruses in Vero cells by MxA protein Virology 224 1996 55 62
18. T. Kawai, M. Seki, K. Hiromatsu, J.W. Eastcott, G.F. Watts, M. Sugai, D.J. Smith, S.A. Porcelli, and M.A. Taubman Selective diapedesis of Th1 cells induced by endothelial cell RANTES J. Immunol. 163 1999 3269 3278
19. S.F. Khaiboullina, A.A. Rizvanov, E. Otteson, A. Miyazato, J. Maciejewski, and J.S. St Regulation of cellular gene expression in endothelial cells by sin nombre and prospect hill viruses Viral. Immunol. 17 2004 234 251
20. G. Krishnaswamy, J. Kelley, L. Yerra, J.K. Smith, and D.S. Chi Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease J. Interferon Cytokine Res. 19 1999 91 104
21. H. Landis, A. Simon-Jodicke, A. Kloti, P.C. Di, J.J. Schnorr, S. Schneider-Schaulies, H.P. Hefti, and J. Pavlovic Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins J. Virol. 72 1998 1516 1522
22. I.J. Mackie, and H.A. Bull Normal haemostasis and its regulation Blood Rev. 3 1989 237 250
23. M.A. McArthur, M.T. Suderman, J.P. Mutebi, S.Y. Xiao, and A.D. Barrett Molecular characterization of a hamster viscerotropic strain of yellow fever virus J. Virol. 77 2003 1462 1468
24. T.P. Monath Yellow fever: an update Lancet Infect. Dis. 1 2001 11 20
25. T.P. Monath, and A.D. Barrett Pathogenesis and pathophysiology of yellow fever Adv. Virus Res. 60 2003 343 395
26. T.P. Monath, K.R. Brinker, F.W. Chandler, G.E. Kemp, and C.B. Cropp Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues Am. J. Trop. Med. Hyg. 30 1981 431 443
27. T.P. Monath, M.E. Ballinger, B.R. Miller, and J.J. Salaun Detection of yellow fever viral RNA by nucleic acid hybridization and viral antigen by immunocytochemistry in fixed human liver Am. J. Trop. Med. Hyg. 40 1989 663 668
28. E.S. Nassar, E.L. Chamelet, T.L. Coimbra, L.T. de Souza, A. Suzuki, I.B. Ferreira, M.V. da Silva, I.M. Rocco, and A.P. Travassos da Rosa Jungle yellow fever: clinical and laboratorial studies emphasizing viremia on a human case Rev. Inst. Med. Trop. Sao Paulo 37 1995 337 341
29. J. Pavlovic, A. Schroder, A. Blank, F. Pitossi, and P. Staeheli Mx proteins: GTPases involved in the interferon-induced antiviral state Ciba Found. Symp. 176 1993 233 243
30. J. Pavlovic, H.A. Arzet, H.P. Hefti, M. Frese, D. Rost, B. Ernst, E. Kolb, P. Staeheli, and O. Haller Enhanced virus resistance of transgenic mice expressing the human MxA protein J. Virol. 69 1995 4506 4510
31. J.A. Quaresma, V.L. Barros, E.R. Fernandes, C. Pagliari, C. Takakura, P.F. da Costa Vasconcelos, H.F de Andrade Jr., and M.I. Duarte Reconsideration of histopathology and ultrastructural aspects of the human liver in yellow fever Acta Trop. 94 2005 116 127
32. T.J. Schall, K. Bacon, K.J. Toy, and D.V. Goeddel Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES Nature 347 1990 669 671
33. R. Seguin, K. Biernacki, R.L. Rotondo, A. Prat, and J.P. Antel Regulation and functional effects of monocyte migration across human brain-derived endothelial cells J. Neuropathol. Exp. Neurol. 62 2003 412 419
34. S.M. Stamatovic, R.F. Keep, S.L. Kunkel, and A.V. Andjelkovic Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase J. Cell Sci. 116 2003 4615 4628
35. J.B. Sundstrom, L.K. McMullan, C.F. Spiropoulou, W.C. Hooper, A.A. Ansari, C.J. Peters, and P.E. Rollin Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells J. Virol. 75 2001 6070 6085
36. J. ter Meulen, M. Sakho, K. Koulemou, N. Magassouba, A. Bah, W. Preiser, S. Daffis, C. Klewitz, H.G. Bae, M. Niedrig, H. Zeller, M. Heinzel-Gutenbrunner, L. Koivogui, and A. Kaufmann Activation of the cytokine network and unfavorable outcome in patients with yellow fever J. Infect. Dis. 190 2004 1821 1827
37. M. Theiler K. Strode Yellow Fever 1951 McGraw-Hill New York 39 136
38. S.P. Van der, A. Gianella, M. Pirard, J. Cespedes, J. Lora, C. Peredo, J.L. Pelegrino, V. Vorndam, and M. Boelaert Urbanisation of yellow fever in Santa Cruz, Bolivia Lancet 353 1999 1558 1562
39. D. Wichmann, H.J. Grone, M. Frese, J. Pavlovic, B. Anheier, O. Haller, H.D. Klenk, and H. Feldmann Hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice J. Virol. 76 2002 8890 8899
40. S.Y. Xiao, H. Zhang, H. Guzman, and R.B. Tesh Experimental yellow fever virus infection in the Golden hamster (Mesocricetus auratus): II. Pathology J. Infect. Dis. 183 2001 1437 1444
41. S.R. Zaki, P.W. Greer, L.M. Coffield, C.S. Goldsmith, K.B. Nolte, K. Foucar, R.M. Feddersen, R.E. Zumwalt, G.L. Miller, and A.S. Khan Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease Am. J. Pathol. 146 1995 552 579